TC
AVEO

Trium Capital’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Trium Capital’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-122,140
Closed -$1.83M – 107
2022
Q4 		$1.83M Buy
+122,140
New +$1.69M 0.67% 46

Trium Capital's AVEO Position: Q1 2023 in Review

Trium Capital sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 122,140 shares — an estimated $1.83M sold.

Trium Capital first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $1.83M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Trium Capital reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Trium Capital sold 122,140 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.83M.
  • Trium Capital first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Trium Capital's AVEO Pharmaceuticals, Inc. position peaked at $1.83M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Trium Capital's 13F filing for Q1 2023, filed 16 May 2023.